Potts
They are all great points, but the market says 1.4c and love doesn't pay the bills.
Lets put aside all our individual outlooks on the NWE team and their management of A2. What a few of us are getting at is the actual position NWE is in right now in relation to TIME, COSTS, the funding of those costs and how it will affect the number of shares on issue and/or NWE's stake in A2.
Market can be like a game of chess. NWE might be the operator and have a 27% stake in A2, but doesn't seem to have too many pieces and is being forced into a check mate imo
- Forums
- ASX - By Stock
- NWE
- arrowsmith 3
arrowsmith 3, page-121
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NWE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online